Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcel Blot-Chabaud

Showing results (51-60 of 63) with videos related to

Pageof 7
Sort By:
The Journal of Biological Chemistry|February 8, 2013
Soluble melanoma cell adhesion molecule (sMCAM/sCD146) promotes angiogenic effects on endothelial progenitor cells through angiomotinJimmy Stalin, Karim Harhouri, Lucas Hubert, et al.
Scientific Reports|November 29, 2019
TH17 cells expressing CD146 are significantly increased in patients with Systemic sclerosisAmira Gabsi, Xavier Heim, Akram Dlala, et al.
Cardiovascular Research|May 13, 2016
Soluble CD146 boosts therapeutic effect of endothelial progenitors through proteolytic processing of short CD146 isoformJimmy Stalin, Karim Harhouri, Lucas Hubert, et al.
Acta Neuropathologica Communications|October 24, 2022
Soluble CD146, a biomarker and a target for preventing resistance to anti-angiogenic therapy in glioblastomaAhmad Joshkon, Emeline Tabouret, Wael Traboulsi, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 10, 2022
Involvement of Multiple Variants of Soluble CD146 in Systemic Sclerosis: Identification of a Novel Profibrotic FactorMarie Nollet, Richard Bachelier, Ahmad Joshkon, et al.
Circulation Research|May 8, 2010
CD146 short isoform increases the proangiogenic potential of endothelial progenitor cells in vitro and in vivoAbdeldjalil Kebir, Karim Harhouri, Benjamin Guillet, et al.
Oncotarget|January 20, 2018
A novel anti-CD146 antibody specifically targets cancer cells by internalizing the moleculeMarie Nollet, Jimmy Stalin, Anaïs Moyon, et al.
The Journal of Investigative Dermatology|June 11, 2022
CD146 at the Interface between Oxidative Stress and the Wnt Signaling Pathway in Systemic SclerosisXavier Heim, Julien Bermudez, Ahmad Joshkon, et al.
Hypertension (Dallas, Tex. : 1979)|March 10, 2021
Endothelial-Specific Deletion of CD146 Protects Against Experimental Glomerulonephritis in MiceAhmed Abed, Aurélie S Leroyer, Panagiotis Kavvadas, et al.
F&S Science|May 13, 2022
Soluble CD146 is increased in preeclampsia and interacts with galectin-1 to regulate trophoblast migration through VEGFR2 receptorSylvie Bouvier, Waël Traboulsi, Sandra M Blois, et al.
Pageof 7

Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
The Journal of Biological Chemistry|February 8, 2013
Soluble melanoma cell adhesion molecule (sMCAM/sCD146) promotes angiogenic effects on endothelial progenitor cells through angiomotinJimmy Stalin, Karim Harhouri, Lucas Hubert, et al.
Scientific Reports|November 29, 2019
TH17 cells expressing CD146 are significantly increased in patients with Systemic sclerosisAmira Gabsi, Xavier Heim, Akram Dlala, et al.
Cardiovascular Research|May 13, 2016
Soluble CD146 boosts therapeutic effect of endothelial progenitors through proteolytic processing of short CD146 isoformJimmy Stalin, Karim Harhouri, Lucas Hubert, et al.
Acta Neuropathologica Communications|October 24, 2022
Soluble CD146, a biomarker and a target for preventing resistance to anti-angiogenic therapy in glioblastomaAhmad Joshkon, Emeline Tabouret, Wael Traboulsi, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 10, 2022
Involvement of Multiple Variants of Soluble CD146 in Systemic Sclerosis: Identification of a Novel Profibrotic FactorMarie Nollet, Richard Bachelier, Ahmad Joshkon, et al.
Circulation Research|May 8, 2010
CD146 short isoform increases the proangiogenic potential of endothelial progenitor cells in vitro and in vivoAbdeldjalil Kebir, Karim Harhouri, Benjamin Guillet, et al.
Oncotarget|January 20, 2018
A novel anti-CD146 antibody specifically targets cancer cells by internalizing the moleculeMarie Nollet, Jimmy Stalin, Anaïs Moyon, et al.
The Journal of Investigative Dermatology|June 11, 2022
CD146 at the Interface between Oxidative Stress and the Wnt Signaling Pathway in Systemic SclerosisXavier Heim, Julien Bermudez, Ahmad Joshkon, et al.
Hypertension (Dallas, Tex. : 1979)|March 10, 2021
Endothelial-Specific Deletion of CD146 Protects Against Experimental Glomerulonephritis in MiceAhmed Abed, Aurélie S Leroyer, Panagiotis Kavvadas, et al.
F&S Science|May 13, 2022
Soluble CD146 is increased in preeclampsia and interacts with galectin-1 to regulate trophoblast migration through VEGFR2 receptorSylvie Bouvier, Waël Traboulsi, Sandra M Blois, et al.
Pageof 7